{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T05:15:56Z","timestamp":1722143756039},"reference-count":37,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.3892\/or.2014.3197","type":"journal-article","created":{"date-parts":[[2014,5,16]],"date-time":"2014-05-16T13:19:21Z","timestamp":1400246361000},"page":"145-152","source":"Crossref","is-referenced-by-count":16,"title":["Presence of the minor EGFR T790M mutation is associated with drug-sensitive EGFR mutations in lung adenocarcinoma patients"],"prefix":"10.3892","volume":"32","author":[{"given":"SHINSUKE","family":"HASHIDA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JUNICHI","family":"SOH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHINICHI","family":"TOYOOKA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TOMOAKI","family":"TANAKA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MASASHI","family":"FURUKAWA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KAZUHIKO","family":"SHIEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HIROMASA","family":"YAMAMOTO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HIROAKI","family":"ASANO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KAZUNORI","family":"TSUKUDA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KOICHI","family":"HAGIWARA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHINICHIRO","family":"MIYOSHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2014,5,16]]},"reference":[{"key":"key20180107210251_b1-or-32-01-0145","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1470-2045(09)70364-X","article-title":"Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial","volume":"11","author":"Mitsudomi","year":"2010","journal-title":"Lancet Oncol"},{"key":"key20180107210251_b2-or-32-01-0145","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1200\/JCO.2007.14.8494","article-title":"First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations","volume":"26","author":"Sequist","year":"2008","journal-title":"J Clin Oncol"},{"key":"key20180107210251_b3-or-32-01-0145","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMoa040938","article-title":"Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib","volume":"350","author":"Lynch","year":"2004","journal-title":"N Engl J Med"},{"key":"key20180107210251_b4-or-32-01-0145","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.lungcan.2008.06.021","article-title":"Impact of EGFR mutation analysis in non-small cell lung cancer","volume":"63","author":"Yamamoto","year":"2009","journal-title":"Lung Cancer"},{"key":"key20180107210251_b5-or-32-01-0145","doi-asserted-by":"crossref","first-page":"8919","DOI":"10.1158\/0008-5472.CAN-04-2818","article-title":"Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications","volume":"64","author":"Kosaka","year":"2004","journal-title":"Cancer Res"},{"key":"key20180107210251_b6-or-32-01-0145","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4137\/CMO.S7340","article-title":"Review of the treatment of non-small cell lung cancer with gefitinib","volume":"6","author":"Araki","year":"2012","journal-title":"Clin Med Insights Oncol"},{"key":"key20180107210251_b7-or-32-01-0145","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1056\/NEJMoa044238","article-title":"EGFR mutation and resistance of non-small-cell lung cancer to gefitinib","volume":"352","author":"Kobayashi","year":"2005","journal-title":"N Engl J Med"},{"key":"key20180107210251_b8-or-32-01-0145","doi-asserted-by":"crossref","first-page":"75ra26","DOI":"10.1126\/scitranslmed.3002003","article-title":"Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors","volume":"3","author":"Sequist","year":"2011","journal-title":"Sci Transl Med"},{"key":"key20180107210251_b9-or-32-01-0145","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1158\/1078-0432.CCR-10-2692","article-title":"Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer: distinct natural history of patients with tumors harboring the T790M mutation","volume":"17","author":"Oxnard","year":"2011","journal-title":"Clin Cancer Res"},{"key":"key20180107210251_b10-or-32-01-0145","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.bbapap.2009.12.010","article-title":"Structural and mechanistic underpinnings of the differential drug sensitivity of EGFR mutations in non-small cell lung cancer","volume":"1804","author":"Eck","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"key20180107210251_b11-or-32-01-0145","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1056\/NEJMoa0800668","article-title":"Detection of mutations in EGFR in circulating lung-cancer cells","volume":"359","author":"Maheswaran","year":"2008","journal-title":"N Engl J Med"},{"key":"key20180107210251_b12-or-32-01-0145","doi-asserted-by":"crossref","first-page":"7854","DOI":"10.1158\/0008-5472.CAN-06-1951","article-title":"Presence of epidermal growth factor receptor gene T790M mutation as a minor clone in non-small cell lung cancer","volume":"66","author":"Inukai","year":"2006","journal-title":"Cancer Res"},{"key":"key20180107210251_b13-or-32-01-0145","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1600-0463.2011.02738.x","article-title":"Detection of low-level EGFR T790M mutation in lung cancer tissues","volume":"119","author":"Oh","year":"2011","journal-title":"APMIS"},{"key":"key20180107210251_b14-or-32-01-0145","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1097\/JTO.0b013e3182653d7f","article-title":"Highly sensitive detection of EGFR T790M mutation using colony hybridization predicts favorable prognosis of patients with lung cancer harboring activating EGFR mutation","volume":"7","author":"Fujita","year":"2012","journal-title":"J Thorac Oncol"},{"key":"key20180107210251_b15-or-32-01-0145","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1158\/1078-0432.CCR-10-2158","article-title":"Pretreatment EGFR T790M mutation and BRCA1 mRNA expression in erlotinib-treated advanced non-small-cell lung cancer patients with EGFR mutations","volume":"17","author":"Rosell","year":"2011","journal-title":"Clin Cancer Res"},{"key":"key20180107210251_b16-or-32-01-0145","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1200\/JCO.2011.38.3224","article-title":"Pretreatment epidermal growth factor receptor (EGFR) T790M mutation predicts shorter EGFR tyrosine kinase inhibitor response duration in patients with non-small-cell lung cancer","volume":"30","author":"Su","year":"2012","journal-title":"J Clin Oncol"},{"key":"key20180107210251_b17-or-32-01-0145","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1056\/NEJM200505193522019","article-title":"EGFR mutation and response of lung cancer to gefitinib","volume":"352","author":"Toyooka","year":"2005","journal-title":"N Engl J Med"},{"key":"key20180107210251_b18-or-32-01-0145","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/labinvest.2011.187","article-title":"WZ4002, a third-generation EGFR inhibitor, can overcome anoikis resistance in EGFR-mutant lung adenocarcinomas more efficiently than Src inhibitors","volume":"92","author":"Sakuma","year":"2012","journal-title":"Lab Invest"},{"key":"key20180107210251_b19-or-32-01-0145","first-page":"3000","article-title":"Dual targeting of EGFR can overcome a major drug resistance mutation in mouse models of EGFR mutant lung cancer","volume":"119","author":"Regales","year":"2009","journal-title":"J Clin Invest"},{"key":"key20180107210251_b20-or-32-01-0145","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1158\/1078-0432.CCR-05-0934","article-title":"Detection of EGFR gene mutation in lung cancer by mutant-enriched polymerase chain reaction assay","volume":"12","author":"Asano","year":"2006","journal-title":"Clin Cancer Res"},{"key":"key20180107210251_b21-or-32-01-0145","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nm1708","article-title":"Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testing","volume":"14","author":"Li","year":"2008","journal-title":"Nat Med"},{"key":"key20180107210251_b22-or-32-01-0145","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1373\/clinchem.2009.136143","article-title":"COLD-PCR finds hot application in mutation analysis","volume":"55","author":"Luthra","year":"2009","journal-title":"Clin Chem"},{"key":"key20180107210251_b23-or-32-01-0145","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1373\/clinchem.2009.131029","article-title":"COLD-PCR-enhanced high-resolution melting enables rapid and selective identification of low-level unknown mutations","volume":"55","author":"Milbury","year":"2009","journal-title":"Clin Chem"},{"key":"key20180107210251_b24-or-32-01-0145","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/PDM.0b013e3181fde92f","article-title":"Rapid and sensitive detection of KRAS mutation after fast-COLD-PCR enrichment and high-resolution melting analysis","volume":"20","author":"Song","year":"2011","journal-title":"Diagn Mol Pathol"},{"key":"key20180107210251_b25-or-32-01-0145","first-page":"5","article-title":"DNA extraction from fresh or frozen tissues","volume":"49","author":"Fan","year":"2001","journal-title":"Methods Mol Med"},{"key":"key20180107210251_b26-or-32-01-0145","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1093\/annonc\/mds121","article-title":"An evaluation study of EGFR mutation tests utilized for non-small-cell lung cancer in the diagnostic setting","volume":"23","author":"Goto","year":"2012","journal-title":"Ann Oncol"},{"key":"key20180107210251_b27-or-32-01-0145","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1158\/1078-0432.1167.11.3","article-title":"The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non-small cell lung cancers","volume":"11","author":"Tokumo","year":"2005","journal-title":"Clin Cancer Res"},{"key":"key20180107210251_b28-or-32-01-0145","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1471-2407-8-142","article-title":"High resolution melting analysis for rapid and sensitive EGFR and KRAS mutation detection in formalin fixed paraffin embedded biopsies","volume":"8","author":"Do","year":"2008","journal-title":"BMC Cancer"},{"key":"key20180107210251_b29-or-32-01-0145","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.lungcan.2012.09.006","article-title":"Impact of age on epidermal growth factor receptor mutation in lung cancer","volume":"78","author":"Ueno","year":"2012","journal-title":"Lung Cancer"},{"key":"key20180107210251_b30-or-32-01-0145","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1349-7006.2006.00347.x","article-title":"Risk factors differ for non-small-cell lung cancers with and without EGFR mutation: assessment of smoking and sex by a case-control study in Japanese","volume":"98","author":"Matsuo","year":"2007","journal-title":"Cancer Sci"},{"key":"key20180107210251_b31-or-32-01-0145","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/ng1671","article-title":"Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR","volume":"37","author":"Bell","year":"2005","journal-title":"Nat Genet"},{"key":"key20180107210251_b32-or-32-01-0145","doi-asserted-by":"crossref","first-page":"e7464","DOI":"10.1371\/journal.pone.0007464","article-title":"Oncogene mutations, copy number gains and mutant allele specific imbalance (MASI) frequently occur together in tumor cells","volume":"4","author":"Soh","year":"2009","journal-title":"PLoS One"},{"key":"key20180107210251_b33-or-32-01-0145","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1371\/journal.pmed.0020073","article-title":"Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain","volume":"2","author":"Pao","year":"2005","journal-title":"PLoS Med"},{"key":"key20180107210251_b34-or-32-01-0145","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1200\/JCO.2010.31.4492","article-title":"Familial lung adenocarcinoma caused by the EGFR V843I germ-line mutation","volume":"29","author":"Ohtsuka","year":"2011","journal-title":"J Clin Oncol"},{"key":"key20180107210251_b35-or-32-01-0145","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1200\/JCO.2012.42.1586","article-title":"Activating germline R776H mutation in the epidermal growth factor receptor associated with lung cancer with squamous differentiation","volume":"31","author":"van Noesel","year":"2013","journal-title":"J Clin Oncol"},{"key":"key20180107210251_b36-or-32-01-0145","doi-asserted-by":"crossref","first-page":"90ra59","DOI":"10.1126\/scitranslmed.3002356","article-title":"Optimization of dosing for EGFR-mutant non-small cell lung cancer with evolutionary cancer modeling","volume":"3","author":"Chmielecki","year":"2011","journal-title":"Sci Transl Med"},{"key":"key20180107210251_b37-or-32-01-0145","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2012.08.024","article-title":"Genomic landscape of non-small cell lung cancer in smokers and never-smokers","volume":"150","author":"Govindan","year":"2012","journal-title":"Cell"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2014.3197\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T05:30:08Z","timestamp":1689226208000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2014.3197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,16]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,5,16]]},"published-print":{"date-parts":[[2014,7]]}},"alternative-id":["10.3892\/or.2014.3197"],"URL":"https:\/\/doi.org\/10.3892\/or.2014.3197","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,16]]}}}